WDA
Wendell David Associates Portfolio holdings
AUM
$994M
This Quarter Return
+1.47%
1 Year Return
+12.84%
3 Year Return
+59.56%
5 Year Return
+107.42%
10 Year Return
+294.8%
AUM
$520M
AUM Growth
+$520M
(+1.5%)
Cap. Flow
+$3.21M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
148
New
3
Increased
48
Reduced
38
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$1.09M |
| 2 |
Hain Celestial
HAIN
|
$1.07M |
| 3 |
Tractor Supply
TSCO
|
$712K |
| 4 |
American Tower
AMT
|
$454K |
| 5 |
iShares Preferred and Income Securities ETF
PFF
|
$420K |
Top Sells
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
$1.16M |
| 2 |
Qualcomm
QCOM
|
$787K |
| 3 |
Walmart
WMT
|
$508K |
| 4 |
iRobot
IRBT
|
$429K |
| 5 |
Automatic Data Processing
ADP
|
$327K |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Consumer Staples | 17.46% |
| 3 | Technology | 16.46% |
| 4 | Industrials | 10.65% |
| 5 | Consumer Discretionary | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Altria Group
MO
$112B
| $358K | 0.07% |
7,150
| – | – |
|
127
Mondelez International
MDLZ
$79.3B
| $345K | 0.07% |
9,575
| – | – |
|
128
Monster Beverage
MNST
$62B
| $331K | 0.06% |
14,400
| – | – |
|
129
Visa
V
$681B
| $329K | 0.06% |
5,060
| – | – |
|
130
Genuine Parts
GPC
$19B
| $326K | 0.06% |
3,500
+425
| +14% | +$39.6K |
|
131
T Rowe Price
TROW
$23.2B
| $312K | 0.06% |
3,850
| – | – |
|
132
Northrop Grumman
NOC
$83.2B
| $309K | 0.06% |
1,920
| – | – |
|
133
SEI Investments
SEIC
$10.8B
| $308K | 0.06% |
7,000
| – | – |
|
|
TWX
134
DELISTED
Time Warner Inc
TWX
| $303K | 0.06% |
3,610
| – | – |
|
135
Oracle
ORCL
$628B
| $293K | 0.06% |
6,819
-200
| -3% | -$8.59K |
|
136
Estee Lauder
EL
$33.1B
| $286K | 0.06% |
3,448
| – | – |
|
|
DD
137
DELISTED
Du Pont De Nemours E I
DD
| $255K | 0.05% |
3,776
| – | – |
|
|
WGL
138
DELISTED
Wgl Holdings
WGL
| $232K | 0.04% |
4,150
| – | – |
|
|
SIRO
139
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $230K | 0.04% |
2,550
| – | – |
|
140
Regeneron Pharmaceuticals
REGN
$59.8B
| $201K | 0.04% |
+445
| New | +$201K |
|